Skip to content

Dexbrompheniramine

Published: July 26, 2026Updated: August 27, 2026

Dexbrompheniramine is a first-generation antihistamine used to relieve symptoms of allergic conditions such as hay fever, allergic rhinitis, and urticaria. It works by blocking histamine H1 receptors, reducing allergic symptoms like sneezing, itching, and runny nose. This medication is available in various formulations including oral tablets and liquid preparations.

Quick summary

A first-generation antihistamine used to treat allergic symptoms by blocking histamine H1 receptors.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ATC
R06AB06
RxNorm
22690
Generic
Dexbrompheniramine
Class
atc-r06
Brands
Ala-Hist IR, M-End Max D
Availability
otc
Pregnancy
B
Lactation
caution
Half-life (h)
25
Onset (min)
30
Duration (h)
6
Routes
oral
Forms
tablet, oral solution
Regions
United States, Canada
Monitoring
sedation, anticholinergic effects

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
2mg every 4 to 6 hours
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
1mg every 4 to 6 hours
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
2mg every 4 to 6 hours
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Consult local poison control center for specific information
Chronic overdose: Varies by patient
Immediate actions
Call poison control center: 1-800-222-1222
Poison Control: 1-800-222-1222

Special Populations

13 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks - may cause fetal toxicity

Monitor

regular fetal monitoring

Use with caution and monitor for adverse effects.

✗

pediatric_age

under 2 years
unsafe
FDA Category
C
Dose Adjustment

contraindicated

Key Recommendations

do not use in children under 2 years of age

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

2 to 6 years
caution
FDA Category
C
Dose Adjustment

use with extreme caution

Key Recommendations

use only under physician supervision - avoid in children with respiratory conditions

Monitor

monitor for sedation and respiratory depression

Use with caution and monitor for adverse effects.

⚠

pediatric_age

6 to 12 years
caution
FDA Category
C
Dose Adjustment

age-appropriate dosing required

Key Recommendations

use under medical supervision - follow weight-based dosing

Monitor

monitor for sedation and anticholinergic effects

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly 65 plus
caution
FDA Category
C
Dose Adjustment

start with lowest effective dose

Key Recommendations

use with caution due to increased sensitivity to anticholinergic effects - avoid in patients with glaucoma, BPH, constipation

Monitor

monitor for sedation, confusion, urinary retention

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild renal impairment
caution
FDA Category
C
Dose Adjustment

no adjustment usually required

Key Recommendations

use with caution - monitor renal function

Monitor

periodic renal function monitoring

Use with caution and monitor for adverse effects.

⚠

renal_impairment

moderate severe renal impairment
caution
FDA Category
C
Dose Adjustment

dose reduction recommended

Key Recommendations

reduce dose and extend dosing interval - monitor closely

Monitor

frequent renal function monitoring required

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild hepatic impairment
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

use with caution - no specific dose adjustment required

Monitor

monitor for increased sedation

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

moderate severe hepatic impairment
caution
FDA Category
C
Dose Adjustment

dose reduction recommended

Key Recommendations

reduce dose - use with caution due to decreased metabolism

Monitor

monitor liver function and for excessive sedation

Use with caution and monitor for adverse effects.

✗

lactation

breastfeeding
unsafe
FDA Category
C
Dose Adjustment

avoid

Key Recommendations

do not use during breastfeeding - appears in breast milk

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

✗

alcohol_users

concurrent alcohol use
unsafe
FDA Category
C
Dose Adjustment

avoid

Key Recommendations

avoid concurrent alcohol use - significantly increases CNS depression

Monitor

monitor for excessive sedation

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

FDA Approval Year

Value:1950s

First generation antihistamine approval timeline

drug_classWHO
2023

Drug Class

Value:Antihistamine (H1 Receptor Antagonist)

Pharmacological classification system

usageMedical guidelines
2023

Primary Therapeutic Uses

Value:Allergic rhinitis, hay fever, common cold symptoms, itching

Approved therapeutic indications

mechanismFDA
2023

Mechanism of Action

Value:H1 receptor blockade

Pharmacodynamic properties

Treatment of allergic rhinitis, hay fever, allergic conjunctivitis, urticaria (hives), and other allergic conditions causing sneezing, itching, watery eyes, and runny nose.

Dexbrompheniramine is an H1 receptor antagonist that competitively blocks histamine at H1 receptor sites, preventing histamine-mediated allergic responses.

May cause drowsiness; avoid alcohol and operating machinery until effects are known. Use with caution in elderly, patients with glaucoma, urinary retention, or thyroid disorders. May interact with other CNS depressants. Consult healthcare provider before use during pregnancy or breastfeeding.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy